4.7 Article

The GM-CSF-IRF5 signaling axis in eosinophils promotes antitumor immunity through activation of type 1 T cell responses

Related references

Note: Only part of the references are listed.
Article Oncology

Activated Eosinophils Exert Antitumorigenic Activities in Colorectal Cancer

Hadar Reichman et al.

CANCER IMMUNOLOGY RESEARCH (2019)

Article Immunology

Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation

Isabelle C. Arnold et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2018)

Article Immunology

CCL22-Producing Resident Macrophages Enhance T Cell Response in Sjogren's Syndrome

Aya Ushio et al.

FRONTIERS IN IMMUNOLOGY (2018)

Review Medicine, General & Internal

Targeting the Interleukin-5 Pathway for Treatment of Eosinophilic Conditions Other than Asthma

Florence Roufosse

FRONTIERS IN MEDICINE (2018)

Review Biochemistry & Molecular Biology

Stimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer types

In-Sun Hong

EXPERIMENTAL AND MOLECULAR MEDICINE (2016)

Review Immunology

Eosinophils in mucosal immune responses

J. Travers et al.

MUCOSAL IMMUNOLOGY (2015)

Article Medicine, General & Internal

Ipilimumab Plus Sargramostim vs Ipilimumab Alone for Treatment of Metastatic Melanoma A Randomized Clinical Trial

F. Stephen Hodi et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)

Article Immunology

Roles and Regulation of Gastrointestinal Eosinophils in Immunity and Disease

YunJae Jung et al.

JOURNAL OF IMMUNOLOGY (2014)

Article Cell Biology

IRF5:RelA Interaction Targets Inflammatory Genes in Macrophages

David G. Saliba et al.

CELL REPORTS (2014)

Review Immunology

Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity

Francis Davoine et al.

FRONTIERS IN IMMUNOLOGY (2014)

Review Allergy

The consequences of not having eosinophils

G. J. Gleich et al.

ALLERGY (2013)

Article Cell Biology

IRF5 Is a Specific Marker of Inflammatory Macrophages In Vivo

Miriam Weiss et al.

MEDIATORS OF INFLAMMATION (2013)

Article Critical Care Medicine

Reslizumab for Poorly Controlled, Eosinophilic Asthma A Randomized, Placebo-controlled Study

Mario Castro et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)

Article Immunology

IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses

Thomas Krausgruber et al.

NATURE IMMUNOLOGY (2011)

Article Multidisciplinary Sciences

Defining a link with asthma in mice congenitally deficient in eosinophils

JJ Lee et al.

SCIENCE (2004)